Applied Genetic Technologies (AGTC) Tops Q2 EPS by 11c

Applied Genetic Technologies (NASDAQ: AGTC) reported Q2 EPS of ($0.28), $0.11 better than the analyst estimate of ($0.39). Revenue for the quarter came in at $652 thousand versus the consensus estimate of $330 thousand.

For earnings history and earnings-related data on Applied Genetic Technologies (AGTC) click here.

You May Also Be Interested In

• Blackhawk Network (HAWK) Reports Q2 Loss of $0.07; Offers Guidance
• 4D Molecular Therapeutics, Inc. (FDMT) Misses Q2 EPS by 3c
• Globant (GLOB) Misses Q2 EPS by 10c, Offers Guidance